Press Releases

Jan 22, 2020 6:30am EST

Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

Jan 14, 2020 6:30am EST

Lexaria Bioscience Corp. and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

Jan 09, 2020 1:50pm EST

Lexaria Provides Strategic Update from CEO

Nov 21, 2019 6:15am EST

Lexaria’s Technology Now Works in Less Than 10 Minutes

Nov 05, 2019 6:15am EST

Lexaria Bioscience Appoints Gregg Smith as Senior Advisor

Oct 24, 2019 6:15am EDT

Lexaria Applauds FDA Decision on Reduced Risk Tobacco Format

Oct 08, 2019 6:15am EDT

Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria

Sep 17, 2019 6:15am EDT

Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results

Sep 06, 2019 8:30am EDT

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery

Sep 05, 2019 8:30am EDT

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation